XERS
NASDAQ HealthcareXeris Biopharma Holdings, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $5.48 |
|---|---|
| Volume | 2,104,017 |
| Market Cap | 944.92M |
| Beta | 0.970 |
| RSI (14-Day) | 24.2 Oversold |
| 200-Day MA | $6.86 |
| 50-Day MA | $6.96 |
| 52-Week High | $10.08 |
| 52-Week Low | $3.81 |
| Forward P/E | 14.81 |
| Price / Book | 66.83 |
🎯 Investment Strategy Scores
How XERS scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
33/100
High dividend yield + low volatility
🚀 Moon Shot
65/100
High growth potential (high beta + oversold)
🔪 Falling Knife
88/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
20/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
24/100
Large-cap, institutional-quality stocks
Find XERS in your text
Paste any text on the homepage — the tool will extract XERS and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.